Tumorsphere as an effective  in vitro  platform for screening anti-cancer stem cell drugs

Che-Hsin Lee; Cheng-Chia Yu; Bing-Yen Wang; Wen-Wei Chang

doi:10.18632/oncotarget.6261

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs

Che-Hsin Lee, Cheng-Chia Yu, Bing-Yen Wang and Wen-Wei Chang _

PDF | HTML | How to cite

Oncotarget. 2016; 7:1215-1226. https://doi.org/10.18632/oncotarget.6261

Metrics: PDF 3514 views | HTML 5811 views | ?

Abstract

Che-Hsin Lee1,2, Cheng-Chia Yu3,4,5, Bing-Yen Wang6,7,8 and Wen-Wei Chang9,10

1 Graduate Institute of Basic Medical Science, School of Medicine, China Medical University, Taichung City, Taiwan

2 Department of Microbiology, School of Medicine, China Medical University, Taichung City, Taiwan

3 School of Dentistry, Chung Shan Medical University, Taichung City, Taiwan

4 Department of Dentistry, Chung Shan Medical University Hospital, Taichung City, Taiwan

5 Institute of Oral Sciences, Chung Shan Medical University, Taichung City, Taiwan

6 Institute of Medicine, Chung Shan Medical University, Taichung City, Taiwan

7 Division of Thoracic Surgery, Department of Surgery, ChangHua Christian Hospital, ChangHua County, Taiwan

8 School of Medicine, National Yang-Ming University, Taipei City, Taiwan

9 School of Biomedical Sciences, Chung Shan Medical University, Taichung City, Taiwan

10 Department of Medical Research, Chung Shan Medical University Hospital, Taichung City, Taiwan

Correspondence to:

Wen-Wei Chang, email:

Keywords: cancer stem cells, tumorsphere, targeting therapy, drug screening

Received: June 11, 2015 Accepted: October 14, 2015 Published: October 31, 2015

Abstract

Cancer stem cells (CSCs) are a sub-population of cells within cancer tissues with tumor initiation, drug resistance and metastasis properties. CSCs also have been considered as the main cause of cancer recurrence. Targeting CSCs have been suggested as the key for successful treatment against cancer. Tumorsphere cultivation is based on culturing cancer cells onto ultralow attachment surface in serum-free media under the supplementation with growth factors such as epidermal growth factor and basic fibroblast growth factor. Tumorsphere cultivation is widely used to analyze the self-renewal capability of CSCs and to enrich these cells from bulk cancer cells. This method also provides a reliable platform for screening potential anti-CSC agents. The in vitro anti-proliferation activity of potential agents selected from tumorsphere assay is more translatable into in vivo anti-tumorigenic activity compared with general monolayer culture. Tumorsphere assay can also measure the outcome of clinical trials for potential anti-cancer agents. In addition, tumorsphere assay may be a promising strategy in the innovation of future cancer therapeutica and may help in the screening of anti-cancer small-molecule chemicals.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 6261

Publication Alerts

Reviews:

Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs

Abstract